J. Thistlethwaite to Drug Resistance
This is a "connection" page, showing publications J. Thistlethwaite has written about Drug Resistance.
Connection Strength
0.086
-
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation. 1996 May 15; 61(9):1365-9.
Score: 0.033
-
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Transplant Proc. 1996 Apr; 28(2):1014.
Score: 0.033
-
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation. 1996 Sep 15; 62(5):594-9.
Score: 0.008
-
Allograft rejection in pediatric recipients of living related liver transplants. Hepatology. 1996 Jan; 23(1):40-3.
Score: 0.008
-
Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts. Am Surg. 1987 Jul; 53(7):407-9.
Score: 0.004